Note: Ingredients listed on restricted chemical lists
EC/CAS
269-789-9/68333-79-9
Name of the chemical
Polyphosphoric acids, ammonium salts
Concentration
≥25-≤50 ≥25-≤50 ≥5%
EC/CAS
216-823-5/1675-54-3
Name of the chemical
2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane
Concentration
≥5% ≥10-≤15
EC/CAS
203-615-4/108-78-1
Name of the chemical
Melamine
Concentration
≥10 - ≤15
EC/CAS
204-112-2/115-86-6
Name of the chemical
Triphenylphosphate
Concentration
≤1
EC/CAS
700-990-0
Name of the chemical
4-tert-butylphenyl diphenyl phosphate bis(4-tert-butylphenyl) phenyl phosphate triphenyl phosphate
Concentration
≤3 ≤3 ≤1
General Information
Revision date
2025-10-20
Product name
CHARTEK ONE GREY PART A
1.2.1 Relevant identified uses
Professional use
1.2.2. Uses advised against
Consumer use
Emergency telephone
+966 3 812 1044, +966 3 812 1169
Icons in SDS
Company Information
company name
AkzoNobel Saudi Arabia Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sdsfellinguk@akzonobel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H317, H319, H351, H361f, H373, H411
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed. H315 - Causes skin irritation. H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H351 - Suspected of causing cancer. H361f - Suspected of damaging fertility. H373 - May cause damage to organs through prolonged or repeated exposure. H411 - Toxic to aquatic life with long lasting effects.
Prevention
P201 - Obtain special instructions before use. P280 - Wear protective gloves, protective clothing, eye protection, face protection, or hearing protection. P273 - Avoid release to the environment. P260 - Do not breathe dust. P270 - Do not eat, drink or smoke when using this product. P264 - Wash hands thoroughly after handling.
Response
P391 - Collect spillage. P308 + P313 - IF exposed or concerned: Get medical advice or attention. P362 + P364 - Take off contaminated clothing and wash it before reuse. P302 + P352 - IF ON SKIN: Wash with plenty of water. P333 + P313 - If skin irritation or rash occurs: Get medical advice or attention. P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 - If eye irritation persists: Get medical advice or attention.
Storage
Not applicable.
Disposal
P501 - Dispose of contents and container in accordance with all local, regional, national or international regulations.
Hazardous Ingredients
Polyphosphoric acids, ammonium salts 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bisoxirane melamine Oxirane, 2-(chloromethyl)-, polymer with α-hydro-ω-hydroxypoly[oxy(methyl- 1,2-ethanediyl)]
Supplemental label elements
Not applicable.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Special packaging requirements
Containers to be fitted with child-resistant fastenings : Not applicable.
Tactile warning of danger
Not applicable.
2.3 Other hazards
Product meets the criteria for PBT or vPvB according : This mixture does not contain any substances that are assessed to be a PBT or a vPvB.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Acute Tox. 4, H302 Skin Irrit. 2, H315 Eye Irrit. 2, H319 Skin Sens. 1, H317 Carc. 2, H351 Repr. 2, H361f STOT RE 2, H373 Aquatic Chronic 2, H411 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. SECTION 2: Hazards identification See Section 11 for more detailed information on health effects and symptoms.
